Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide for Prevention of Acute Kidney Injury in Prolonged Cardiopulmonary Bypass
NCT02836899Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Feb 2017
- Primary completion
- Aug 2025
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of nitric oxide in acute kidney injury (AKI), sponsored by Massachusetts General Hospital. Started Feb 2017; status: completed.
02
Drugs
nitric oxide
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02836899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02836899.